Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adipose-derived mesenchymal stem cells for rotator cuff tendon tear
IRCT20100718004409N15Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of autologous adipose-derived mesenchymal stromal cells in rotator cuff tear (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Pain. Started Jun 2024; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on IRCT20100718004409N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100718004409N15.